Overview

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Determine whether patients receiving adjuvant HSPPC-96 treatment after surgically resected, locally advanced renal cell carcinoma have improved recurrence-free survival as compared to subjects with no adjuvant treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Agenus Inc.